- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Supriya Lifescience announced standalone financial results: Q3 FY26 revenue ₹206.44 Cr & profit ₹49.68 Cr. The board also approved nine-month results and re-appointed one, and appointed two new Independent Directors.